Comparison of the effect of different dual antiplatelet therapy in Acute Coronary Syndrome Patients after PCI surgery

Status

Recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-OPC-16008963

Enrollment

Unknown

Registered

2016-08-03

Start date

2016-01-08

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Coronary Syndromes

Interventions

Case series:antiplatelet therapy

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: The ACS was diagnosed according to the European Society of Cardiology (ESC) criteria. All patients had angina pectoris or a positive stress test, and had native coronary artery lesions for which DES implantation was feasible.

Exclusion criteria

Exclusion criteria: Patients were excluded if they had contraindication to clopidogrel or cilostazol; age less than 18 years; left ventricular ejection fraction <30%; platelet count<100,000/mm3; severe liver and kidney insufficiencyacute and chronic infection.

Design outcomes

Primary

Measure	Time frame
adenosine;cAMP;	—

Contacts

Public ContactLv Qianzhou

Zhongshan Hospital, Fudan University

Qianzhou_Lv@163.com+86 21-34160880

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026